TARGET Pharmasolutions
1450 Raleigh Road, Suite 212
Chapel Hill
North Carolina
27517
United States
Tel: 984-234-0268
Website: https://targetpharmasolutions.com/
About TARGET Pharmasolutions
TARGET PharmaSolutions is a real world clinical data company that delivers solutions to improve clinical, medical, and commercial outcomes. The TARGET model organizes a community of stakeholders, including pharmaceutical partners, key opinion leaders, regulatory agencies, and patient advocacy groups, around a specific disease to generate real world clinical data and insights about the natural history of the disease, including treatment outcomes.
Key differentiators of TARGET PharmaSolutions include:
We Deliver Rapid, Cost Effective Solution to Collect Population-Based Real World Data
We Enhance Commercial Opportunity
We Increase Academic/Clinical and Regulatory Interactions
We Maximize the Value of the Data
11 articles about TARGET Pharmasolutions
-
Novel Real-World Data Findings From Ongoing TARGET-IBD Study Published In DDW Proceedings
5/7/2020
TARGET PharmaSolutions, an innovative healthcare data company that generates real-world clinical data and evidence, announced today the latest research findings from its inflammatory bowel disease study (TARGET-IBD), which was published in the May issue of the peer-reviewed journal Gastroenterology.
-
TARGET PharmaSolutions Launches Real-World Asthma Study
3/13/2020
TARGET PharmaSolutions Inc., a real-world evidence clinical data company, announced today the launch of its seventh observational cohort study, TARGET-ASTHMA.
-
TARGET PharmaSolutions® Launches TARGET-DERM Real-World Observational Study to Advance the Understanding of Atopic Dermatitis (Eczema) and Other Immune-Mediated Inflammatory Skin Conditions
2/13/2019
First Patient Enrolled in Longitudinal Study That Will Include Up to 15,000 Patients
-
TARGET PharmaSolutions® Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis B
10/31/2018
TARGET-HBV is an observational study that will conduct a comprehensive review of patients with chronic hepatitis B virus (HBV) infection.
-
TARGET PharmaSolutions to Advance NASH Research Through New Collaboration
1/10/2018
TARGET Pharmasolutions, a real-world data solutions company, is pleased to announce that Novartis has entered into a long-term strategic alliance for TARGET-NASH.
-
Intercept Pharma Extends Strategic Partnership With TARGET Pharmasolutions For TARGET-NASH
10/13/2017
-
Bristol-Myers Squibb Extends Strategic Partnership With TARGET Pharmasolutions For TARGET-NASH
10/12/2017
-
TARGET Pharmasolutions Enrolls First Participant In Its Inflammatory Bowel Disease (IBD) Community
8/2/2017
-
Allergan Partners With TARGET Pharmasolutions To Advance NASH Research
4/20/2017
-
TARGET Pharmasolutions Announces The Launch Of TARGET-PBC (Primary Biliary Cholangitis)
10/4/2016
-
TARGET Pharmasolutions Launches Two Disease State Communities To Better Understand Real World Outcomes
10/3/2016